- Accuratus Lab Services acquires certain assets and assumes certain liabilities related to Array BioPharma's (NASDAQ:ARRY) chemistry, manufacturing and controls (CMC) business. The deal includes the transfer of equipment, inventory and third party contracts related to the CMC business in addition to its facilities lease in Longmont, CO and 33 employees.
- Under the terms of the deal, Array receives an undisclosed cash payment and will be entitled to earn additional consideration contingent on the achievement of revenue targets for years one and two following the close of the transaction.
- Array is up 2% premarket on light volume.